| View |
|
BR-325
|
Diphtheria-Tetanus Toxoid ( DT )
|
Ditevac
|
30 IU/ 40 IU per 0.5 mL
|
Suspension for Injection (IM) (Pediatric-Single Dose)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
Renewal
|
10 August 2021
|
27 September 2026
|
| View |
|
BR-326
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
5 Lf per 0.5mL
|
Suspension for Injection (IM)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
Automatic Renewal
|
10 August 2021
|
07 July 2026
|
| View |
|
BR-334
|
Hepabig
|
Hepatitis B Immunoglobulin (Human)
|
100 IU/0.5 mL
|
Solution For Injection
|
Immunoglobulin
|
Green Cross Corporation
|
Korea
|
Renewal
|
19 April 2022
|
06 April 2027
|
| View |
|
BR-349
|
Measles Vaccine (Live, Attenuated)
|
M-Vac
|
None
|
Lyophilized Powder for Injection (SC)
|
Vaccines
|
Serum Institute of India Pvt., Ltd.
|
India
|
Initial (Variation)
|
27 February 2024
|
27 February 2029
|
| View |
|
BR-359
|
Clostridium botulinum Type A Neurotoxin Complex
|
Botox
|
100 Units
|
Lyophilized Powder for Injection (IM)
|
-
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Regular Renewal
|
26 February 2021
|
26 September 2025
|
| View |
|
BR-404
|
Hepatitis A (inactivated) and hepatitis B (rDNA)
(HAB) vaccine (adsorbed)
|
Twinrix Adult
|
720 ELISA Units/20 mcg per mL
|
Suspension For Injection (I.M.)-Thiomersal Free
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
26 February 2021
|
19 May 2025
|
| View |
|
BR-409
|
Factor IX Complex
|
Profilnine SD
|
1000 IU/10mL
|
Iv
|
Plasma Fraction for Specific Use
|
Grifols Biologicals Inc.
|
U.S.A
|
Renewal
|
09 August 2019
|
05 October 2028
|
| View |
|
BR-411
|
Factor IX Complex
|
Profilnine SD
|
500 IU/5mL%
|
Iv
|
Plasma Fraction for Specific Use
|
Grifols Biologicals Inc.
|
U.S.A
|
Renewal
|
09 August 2019
|
16 October 2028
|
| View |
|
BR-415
|
Measles, Mumps, Rubella (MMR) Vaccine (Live, attenuated) [see formulation on reverse side]
|
Priorix
|
After reconstitution, each dose (0.5mL) contains:
Measles virus (Schwarz strain), live attenuated NLT 10 3.0 CCID 50
Mumps virus (RIT4385 strain), live attenuated NLT 10 3.7 CCID 50
Rubella virus (Wistar RA 27/3 strain), live attenuated NLT 10 3.0 CCID 50
|
Powder for Solution for Injection (SC)
|
-
|
GSK Biologicals SA
|
Belgium
|
-
|
30 March 2021
|
04 May 2026
|
| View |
|
BR-434
|
Measles, Mumps and Rubella Vaccine (Live, Attenuated)
|
Tresivac
|
Formulation: After reconstitution, one dose (0.5 mL) contains: Measles Virus-NLT 1,000 CCID 50 Mumps Virus-NLT 5,000 CCID 50 Rubella Virus -NLT 1,000 CCID 50
|
Freeze-dried Powder for Suspension for Injection (SC)
|
-
|
Serum Institute of India Private Limited
|
India
|
Initial (Variation)
|
04 October 2022
|
04 October 2027
|
| View |
|
BR-435
|
Tetanus Toxoid ( Adsorbed )
|
T-Vac
|
5Lf per 0.5mL
|
Suspension For Injection (I.M)
|
-
|
Serum Institue of India Private Limited
|
India
|
-
|
18 March 2022
|
07 July 2026
|
| View |
|
BR-442
|
Human Albumin
|
Human Albumin 20% Behring (Low Salt)
|
0.002
|
Solution for Intravenous Infusion
|
Plasma Fraction for Specific Use
|
CSL Behring GmbH
|
Germany
|
Renewal
|
06 August 2024
|
06 January 2030
|
| View |
|
BR-445
|
Human Plasma Coagulation Factor VIII
|
Beriate
|
100 IU/mL (250 IU/2.5 mL)
|
Powder for Intravenous Injection or Infusion
|
Plasma Fractions for Specific Use
|
CSL Behring GmbH
|
Germany
|
Renewal
|
03 June 2020
|
03 January 2025
|
| View |
|
BR-446
|
Human Plasma Coagulation Factor VIII
|
Beriate
|
100 IU/mL (500 IU/5 mL)
|
Powder for Intravenous Injection or Infusion
|
Plasma Fractions for Specific Use
|
CSL Behring GmbH
|
Germany
|
Renewal
|
03 June 2020
|
03 January 2025
|
| View |
|
BR-448
|
Albumin (Human)
|
Albuminar
|
0.25
|
Solution for Injection (I.V.)
|
Plasma Fractions for Specific Use
|
CSL Behring LLC
|
U.S.A.
|
Renewal
|
27 April 2021
|
27 January 2025
|
| View |
|
BR-451
|
Diphtheria-Tetanus Toxoids ( Adsorbed )
|
Ditevac
|
0.5mL
|
Suspension For Injection(Im) Multidose
|
-
|
Serum Institute of India Ltd.
|
India
|
-
|
08 September 2020
|
18 April 2025
|
| View |
|
BR-456
|
Sero-Tet
|
Tetanus Immune Globulin Human
|
250 IU/mL
|
Solution For Injection (IM)
|
-
|
Green Cross Corp.
|
Korea
|
-
|
14 May 2021
|
26 April 2025
|
| View |
|
BR-458
|
I.V. - Globulin SN Injection
|
Human Normal Immunoglobulin (IGIV)
|
50mg/mL (500 mg/10 mL)
|
Solution For Injection (IV)
|
-
|
Green Cross Corp.
|
Korea
|
-
|
14 May 2021
|
09 May 2025
|
| View |
|
BR-459
|
Human Albumin
|
Albumax
|
0.2
|
Solution For Injection (IV)
|
-
|
Green Cross Corp.
|
Korea
|
Renewal (Reconstruction)
|
23 May 2022
|
23 May 2025
|
| View |
|
BR-463
|
Human Albumin
|
Albutein 25% Solution
|
0.25
|
Solution for Injection for Infusion (IV)
|
-
|
Grifols Biologicals LLC
|
U.S.A
|
Renewal
|
28 April 2023
|
25 May 2027
|